TLCR: Summary for Talecris Biotherapeutics Holdin - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 5:05am EST - Canadian Markets open in 4 hours and 25 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Talecris Biotherapeutics Holdin (TLCR)

On Feb 9: 22.50 USD 0.00 (0.00%)

MORE ON TLCR

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Talecris Biotherapeutics Holdin (NasdaqNM:TLCR) Delayed quote data

Last Trade:	22.50 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	22.50
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	18.01 - 24.41
Volume:	0
Avg Vol (3m):	516,910
Market Cap:	2.70B
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m

Free Annual Reports

Add TLCR to Portfolio

Download Data

HEADLINES

•	Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Alpha1-Proteinase Inhibitor to Treat Alpha1-Antitrypsin Deficiency
	Business Wire (Fri, Feb 5)

•	A Drugless Drugmaker IPO!
	at Motley Fool (Thu, Feb 4)

•	Stephen Simpson Of Northland Securities Picks 4 Health Care Stock Winners For 2010
	Wall Street Transcript (Wed, Jan 27)

•	HiSeq 2000 Genomics System Begins New Generation Of Innovation In DNA Sequencing Sector Of Biotech And Medical Diagnostics Industry
	Wall Street Transcript (Mon, Jan 25)

•	After A Sluggish Year, VCs Eye Improvement
	Investor's Business Daily (Fri, Jan 8)

•	Talecris Biotherapeutics to Present at the 28th Annual J.P. Morgan Healthcare Conference
	Business Wire (Fri, Jan 8)

•	PhRMA adds 7 biotech companies to its membership
	AP (Fri, Jan 8)

•	Talecris Biotherapeutics Appoints Drayton Virkler as Senior Director, Investor Relations
	Business Wire (Fri, Jan 8)

•	Coverage initiated on Talecris Biotherapeutics by BWS Financial
	Briefing.com (Tue, Jan 5)

•	TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Stat
	EDGAR Online (Thu, Dec 17)

More Headlines for TLCR...

BUSINESS SUMMARY

No business summary available for TLCR.

Add to Portfolio

Email to a Friend

•